On the other hand, the carriers who developed ATLL harbored dominant clones expanded in a monoclonal or oligoclonal manner, and the clones already had several mutations (e.g., PLCG1, VAV1, and STAT3), which are findings consistent with those of a previous study [74]. The gene discussed is PLCG1; the disease is adult T-cell leukemia/lymphoma.